8月,艾联纳医药科技正式宣布完成超1亿元Seed+轮融资。本轮融资由上海未来产业基金、上海国投先导与齐济投资共同领投,中科创星参与投资,老股东高榕、济峰及Plaisance Capital持续加码。
本文源自:金融界AI电报
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.